This seems to be one of the critical questions in the evaluation of whether the merger should go through. We’ve always talked about the Big 3 PBMs – Express Scripts, Medco, and CVS Caremark. If that’s the market, then going from 3 to 2 seems like a huge deal.
But, I think the market has and is changing.
- What about OptumRx (formerly Prescription Solutions)? Once the lives formerly managed by Medco are insourced in 2013, this is going to be > $20B company (I believe) which is part of a huge company (United Healthcare).
- What about Prime Therapeutics? They manage over 14M members (I believe) and have been actively bringing in lots of new management from other PBMs as part of their growth strategy.
- What about SXC and CatalystRx? They both have shown their ability to win against the “Big 3” and grow.
- What about “captive PBMs” like Humana and CIGNA? I think they would both want a bigger crack at the lives outside their insured book of business.
- What about MedImpact? They manage 35M lives today.
Today’s session in DC will certainly be interesting.
[As noted before, I both own shares in some of the companies mentioned here and do business with others and/or seek to do business with the companies mentioned here.]

September 20, 2011 


No comments yet... Be the first to leave a reply!